Authors:
GELS ME
MARRINK J
VISSER P
SLEIJFER DT
DROSTE JHJ
HOEKSTRA HJ
ANDREWS PW
KOOPS HS
Citation: Me. Gels et al., IMPORTANCE OF A NEW TUMOR-MARKER TRA-1-60 IN THE FOLLOW-UP OF PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Annals of surgical oncology, 4(4), 1997, pp. 321-327
Citation: Jpa. Vanbasten et al., CISPLATIN-BASED CHEMOTHERAPY CHANGES THE INCIDENCE OF BILATERAL TESTICULAR CANCER, Annals of surgical oncology, 4(4), 1997, pp. 342-348
Citation: Jpa. Vanbasten et al., SEXUAL DYSFUNCTION IN NONSEMINOMA TESTICULAR CANCER-PATIENTS IS RELATED TO CHEMOTHERAPY-INDUCED ANGIOPATHY, Journal of clinical oncology, 15(6), 1997, pp. 2442-2448
Citation: Jp. Vanbasten et al., SEXUAL FUNCTIONING AFTER MULTIMODALITY TREATMENT FOR DISSEMINATED NONSEMINOMATOUS TESTICULAR GERM-CELL TUMOR, The Journal of urology, 158(4), 1997, pp. 1411-1416
Authors:
GELS ME
NIJBOER AP
HOEKSTRA HJ
SLEIJFER DT
MOLENAAR WM
PLUKKER JT
DROSTE JHJ
KOOPS HS
Citation: Me. Gels et al., COMPLICATIONS OF THE POSTCHEMOTHERAPY RESECTION OF RETROPERITONEAL RESIDUAL TUMOR MASS IN PATIENTS WITH NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, British Journal of Urology, 79(2), 1997, pp. 263-268
Authors:
LEMMERS NWM
GELS ME
SLEIJFER DT
PLUKKER JT
VANDERGRAAF WTA
DELANGEN ZJ
DROSTE JHJ
KOOPS HS
HOEKSTRA HJ
Citation: Nwm. Lemmers et al., COMPLICATIONS OF VENOUS ACCESS PORTS IN 132 PATIENTS WITH DISSEMINATED TESTICULAR CANCER TREATED WITH POLYCHEMOTHERAPY, Journal of clinical oncology, 14(11), 1996, pp. 2916-2922
Authors:
KERKHOF M
DROSTE JHJ
DEMONCHY JGR
SCHOUTEN JP
RIJCKEN B
Citation: M. Kerkhof et al., DISTRIBUTION OF TOTAL SERUM IGE AND SPECIFIC IGE TO COMMON AEROALLERGENS BY SEX AND AGE, AND THEIR RELATIONSHIP TO EACH OTHER IN A RANDOM SAMPLE OF THE DUTCH GENERAL-POPULATION AGED 20-70 YEARS, Allergy, 51(11), 1996, pp. 770-776
Authors:
DROSTE JHJ
KERKHOF M
DEMONCHY JGR
SCHOUTEN JP
RIJCKEN B
Citation: Jhj. Droste et al., ASSOCIATION OF SKIN-TEST REACTIVITY, SPECIFIC IGE, TOTAL IGE, AND EOSINOPHILS WITH NASAL SYMPTOMS IN A COMMUNITY-BASED POPULATION STUDY, Journal of allergy and clinical immunology, 97(4), 1996, pp. 922-932
Citation: Me. Gels et al., DETECTION OF RECURRENCE IN PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS AND CONSEQUENCES FOR FURTHER FOLLOW-UP - A SINGLE-CENTER 1O-YEAR EXPERIENCE, Journal of clinical oncology, 13(5), 1995, pp. 1188-1194